The Emerging Role of Biosimilars

A 1-hour continuing education program for pharmacists

Available until March 14, 2018

Full accreditation information and disclosures are available at:



In this webinar, the presenter will describe the importance of biosimilars, discuss their impact on patient care and disease management, and identify potential implications for pharmacists in different practice settings.


Learning Objectives

After participating in this activity, the pharmacist will be able to:

  1. Describe the importance of biosimilars and their development.
  2. Discuss the impact of biosimilars for patient care and disease management.
  3. Identify key elements of the FDA’s draft guidance for developing biosimilars.
  4. Identify potential implications of biosimilars for pharmacists working in various practice settings.